Literature DB >> 28581469

Administration of high-dose chemotherapy with stem cell support in patients 40 years of age or older with advanced germ cell tumours: a retrospective study from the European Society for Blood and Marrow Transplantation database.

A Necchi1, S Lo Vullo1, G Rosti2, M Badoglio3, P Giannatempo1, D Raggi1, S Secondino2, L Mariani1, F Lanza4, P Pedrazzoli2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28581469     DOI： 10.1038/bmt.2017.106

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

1.  A note on quantifying follow-up in studies of failure time.

Authors:  M Schemper; T L Smith
Journal:  Control Clin Trials       Date:  1996-08

2.  Age ≥40 Years Is Associated with Adverse Outcome in Metastatic Germ Cell Cancer Despite Appropriate Intended Chemotherapy.

Authors:  Rowan E Miller; Sarah C Markt; Elizabeth O'Donnell; Brandon Bernard; Laurence K Albiges; Clair Beard; Christopher J Sweeney
Journal:  Eur Urol Focus       Date:  2016-10-26

3.  Conditional Survival of Patients With Metastatic Testicular Germ Cell Tumors Treated With First-Line Curative Therapy.

Authors:  Jenny J Ko; Brandon Bernard; Ben Tran; Haocheng Li; Tehmina Asif; Igor Stukalin; Margaret Lee; Daphne Day; Nimira Alimohamed; Christopher J Sweeney; Philippe L Bedard; Daniel Y C Heng
Journal:  J Clin Oncol       Date:  2016-01-19       Impact factor: 44.544

4.  Prognostic Factors and Treatment Results After Bleomycin, Etoposide, and Cisplatin in Germ Cell Cancer: A Population-based Study.

Authors:  Maria G Kier; Jakob Lauritsen; Mette S Mortensen; Mikkel Bandak; Klaus K Andersen; Merete K Hansen; Mads Agerbaek; Niels V Holm; Susanne O Dalton; Christoffer Johansen; Gedske Daugaard
Journal:  Eur Urol       Date:  2016-09-17       Impact factor: 20.096

5.  A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.

Authors:  Andrea Necchi; Gregory R Pond; Nicola Nicolai; Patrizia Giannatempo; Daniele Raggi; Nabil Adra; Nasser H Hanna; Roberto Salvioni; Lawrence H Einhorn; Costantine Albany
Journal:  Clin Genitourin Cancer       Date:  2016-08-08       Impact factor: 2.872

6.  Prognostic factors in patients with poor-risk germ-cell tumors: a retrospective analysis of the Indiana University experience from 1990 to 2014.

Authors:  N Adra; S K Althouse; H Liu; M J Brames; N H Hanna; L H Einhorn; C Albany
Journal:  Ann Oncol       Date:  2016-02-09       Impact factor: 32.976

7.  TI-CE high-dose chemotherapy for patients with previously treated germ cell tumors: results and prognostic factor analysis.

Authors:  Darren R Feldman; Joel Sheinfeld; Dean F Bajorin; Patricia Fischer; Stefan Turkula; Nicole Ishill; Sujata Patil; Manjit Bains; Lilian M Reich; George J Bosl; Robert J Motzer
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

8.  Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.

Authors:  Darren R Feldman; Martin H Voss; Erin P Jacobsen; Xiaoyu Jia; J Andres Suarez; Stefan Turkula; Joel Sheinfeld; George J Bosl; Robert J Motzer; Sujata Patil
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

9.  Survival and toxicity in patients with disseminated germ cell cancer aged 40 years and older.

Authors:  Frederik B Thomsen; Mikkel Bandak; Maria F Thomsen; Jakob Lauritsen; Ib J Christensen; Gedske Daugaard
Journal:  Cancer       Date:  2013-09-24       Impact factor: 6.860

10.  Changes in epidemiologic features of testicular germ cell cancer: age at diagnosis and relative frequency of seminoma are constantly and significantly increasing.

Authors:  Christian G Ruf; Hendrik Isbarn; Walter Wagner; Margit Fisch; Cord Matthies; Klaus-Peter Dieckmann
Journal:  Urol Oncol       Date:  2013-02-06       Impact factor: 3.498
View more
  2 in total

1.  Autologous Hematopoietic Stem Cell Transplantation for Male Germ Cell Tumors: Improved Outcomes Over 3 Decades.

Authors:  Deepak Kilari; Anita D'Souza; Raphael Fraser; Muna Qayed; Omar Davila; Vaibhav Agrawal; Miguel Angel Diaz; Saurabh Chhabra; Jan Cerny; Edward Copelan; Nosha Farhadfar; Cesar O Freytes; Robert Peter Gale; Siddhartha Ganguly; Gerhard C Hildebrandt; Leona Holmberg; Rammurti T Kamble; Prashant Kapoor; Hillard Lazarus; Cindy Lee; Hemant S Murthy; Seema Naik; Taiga Nishihori; Ayman Saad; Bipin N Savani; Sachiko Seo; Anne Warwick; Baldeep Wirk; Jean A Yared; Yago Nieto; Parameswaran Hari
Journal:  Biol Blood Marrow Transplant       Date:  2019-02-20       Impact factor: 5.742

Review 2.  Testicular tumors in the "elderly" population.

Authors:  Simona Secondino; Giovanni Rosti; Antonino C Tralongo; Franco Nolè; Domiziana Alaimo; Ornella Carminati; Richard Lawrence John Naspro; Paolo Pedrazzoli
Journal:  Front Oncol       Date:  2022-09-16       Impact factor: 5.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.